Skip to main content
Screener/Healthcare/Biotechnology

AKBA — Akebia Therapeutics, Inc.

NASDAQ
$1.16-0.03 (-2.12%)
Small CapPenny StockUnder $5Healthcare
$1.13
$4.08
$1.13
$1.20
EPS (TTM)$-0.07
P/E Ratio-70.50
Dividend Yield—
Market Cap$389.0M
Volume3.56M
Prev Close$1.18
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$53.5M-$9.1M$-0.0377.0%-16.9%
Q4 '25$57.6M-$12.2M$-0.0578.8%-21.2%
Q3 '25$58.8M$540K$0.0083.5%0.9%
Q2 '25$62.5M$247K$0.0084.1%0.4%
Q1 '25$57.3M$6.1M$0.0386.7%10.7%
Q4 '24$46.5M-$22.8M$-0.1056.2%-49.0%
Q3 '24$37.4M-$20.0M$-0.1062.2%-53.5%
Q2 '24$43.6M-$8.6M$-0.0481.0%-19.7%
Get Your Daily Market Recap